A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/AB67BCBA.svg?ark=w1%2F20260515%2FAB67BCBA)](https://nobleid.org/work/w1/20260515/AB67BCBA)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors